Bioactivation of monocrotaline by P-450 3A in rat liver.

Monocrotaline (MCT) is bioactivated in liver cytochrome P-450s to MCT pyrrole (MCTP), which primarily injures the lung endothelium to result in the development of pulmonary hypertension (PH) in rats. However, whether there is a relation between the degree of PH and the activity of liver cytochrome P-450 to convert MCT to MCTP remains unclear. To examine the relation between these physiological and biochemical changes, we first measured the severity of MCT-induced (20 mg/kg) PH in male, female, castrated male, and phenobarbital (PB, liver P-450s inducer)-pretreated male rats. The degree of right ventricular hypertrophy was more severe in PB-pretreated male than in control male rats. It was also more severe in male than in either female or castrated male rats, suggesting that sex-specific P-450s could be involved in the metabolic pathways of MCT in the liver. Further to explore which of the isozymes (2A2, 2C11, and 3A) of P-450s in the liver is responsible for the bioactivation of MCT, we measured the rate of MCTP production in hepatic microsomes by a modified Mattock's method. Treatment of male rats with PB and pregnenolone 16alpha-carbonitrile (PCN), which is the specific inducer of P-450 3A, increased the rate of MCTP production, suggesting that P-450 3A may contribute to the conversion to pyrrole. Therefore we measured the amount of P-450 3A protein by immunoblotting and attempted to inhibit MCT metabolism by using antibodies to P-450 3A. P-450 3A was significantly induced by PCN (6.5-fold) and PB (4.6-fold) treatment and reduced by castration (0.38-fold). The amount of P-450 3A was closely correlated with the production of MCTP, and the conversion of MCT to MCTP was strongly inhibited by antibodies against P-450 3A. These results indicated that P-450 3A was predominantly responsible for the metabolism of MCT to MCTP in rat liver and suggested a tight linkage between the degree of PH and the activity of liver P-450 3A.

[1]  F. Guengerich,et al.  Selective inhibitors of cytochromes P450. , 1994, Toxicology and applied pharmacology.

[2]  A. Hacker Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension. , 1993, Biochemical pharmacology.

[3]  J. Wagner,et al.  Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium. , 1993, Toxicology and applied pharmacology.

[4]  A. D. Jones,et al.  COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. , 1993, Toxicology and applied pharmacology.

[5]  R. Huxtable,et al.  Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline. , 1992, Toxicology and applied pharmacology.

[6]  J. Wagner,et al.  Early indications of monocrotaline pyrrole-induced lung injury in rats. , 1991, Toxicology and applied pharmacology.

[7]  C. Miranda,et al.  Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. , 1991, Carcinogenesis.

[8]  D. Morin,et al.  Metabolism of [14C]monocrotaline by isolated perfused rat liver. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[9]  J. Reindel,et al.  Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. , 1991, Advances in experimental medicine and biology.

[10]  J. Wagner,et al.  Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. , 1990, Toxicology and applied pharmacology.

[11]  F. Gonzalez,et al.  Molecular genetics of the P-450 superfamily. , 1990, Pharmacology & therapeutics.

[12]  R. Huxtable Activation and pulmonary toxicity of pyrrolizidine alkaloids. , 1990, Pharmacology & therapeutics.

[13]  D. Williams,et al.  Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[14]  A. Molteni,et al.  Monocrotaline pneumotoxicity in mice , 1989, Virchows Archiv B Cell Pathology Including Molecular Pathology.

[15]  D. Waxman,et al.  Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. , 1985, Biochemistry.

[16]  P. Svoboda,et al.  Vanadyl (VO2+) and vanadate (VO-3) ions inhibit the brain microsomal Na,K-ATPase with similar affinities. Protection by transferrin and noradrenaline. , 1984, Biochemical pharmacology.

[17]  F. Guengerich,et al.  Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.

[18]  I. White,et al.  Estimation of metabolites of pyrrolizidine alkaloids in animal tissues. , 1970, Analytical biochemistry.

[19]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[20]  Fulton Rm,et al.  VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY , 1952 .

[21]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.